S.C. Review Board Approves $7 Million for Clemson-GHS Partnership
CONTACT: Chris Przirembel, (864) 656-7701
e-mail: [email protected]
WRITER: Cathy Sams, (864) 656-4233
e-mail: [email protected]
S.C. REVIEW BOARD APPROVES $7 MILLION
FOR CLEMSON-GHS PARTNERSHIP
CLEMSON — Clemson University’s request for $7 million to support a research alliance with the Greenville Hospital System was approved today (Sept. 16) by the South Carolina Research Centers of Economic Excellence Review Board, paving the way for Clemson faculty and students to work directly with GHS clinicians at the Greenville campus to improve patient care and boost economic development.
The Review Board approved Clemson’s request for funding through the state’s Research University Infrastructure Bond Act, which requires matching funds from a non-state source – in this case, facilities to be provided by GHS.
GHS will provide Clemson with 57,000 square feet of space for research in three key areas: bioengineering focused on orthopedic and cardiovascular devices, rehabilitation and performance enhancement at GHS’s Patewood Medical Campus; trauma data analysis and research to guide safer automotive design; and expansion of the oncology-related research currently conducted at the Greenville Hospital System Oncology Research Institute. The facilities and associated infrastructures are valued at $9 million. The $7 million in matching state funds will be used to upfit and equip the facilities that will house the Innovative Biomedicine and Bioengineering Research and Training Program on the campus of the GHS University Medical Center.
Clemson President James F. Barker called the initiative a natural evolution of an already productive 14-year partnership between Clemson and GHS. “Universities are in the business of creating knowledge, but we often need partners to help us deliver that knowledge to people who need it. Clemson has one of the nation’s oldest and strongest bioengineering and biomedical sciences programs, but we need partners in the health care delivery system to maximize the impact of our research efforts,” Barker said.
Targeted research areas will include cardiovascular science and engineering, orthopedic performance and biomechanics, regenerative medicine, tissue engineering, advanced surgical technologies and drug development.
Chris Przirembel, Clemson’s vice president for research and economic development, said the partnership will help Clemson recruit additional bioengineering and biomedical sciences faculty and will enhance both undergraduate and graduate education programs.
“This partnership provides the world-class facilities needed to attract world-class faculty. It creates opportunities for students to experience the real-world application of the science by working side-by-side with physicians and clinicians,” he said. “It also will make our faculty more competitive for external funding from federal agencies, such as the National Institutes of Health. It bridges the gap between research and development and patient care.”